Bernhard Mittemeyer
Corporate Officer/Principal at Texas Tech University Health Sciences Center
Profile
Dr. Bernhard Mittemeyer, MD, is Independent Director at Hemobiotech, Inc. and a Professor-Urological Surgery at Texas Tech University Health Sciences Center.
He is on the Board of Directors at Hemobiotech, Inc.
He received his doctorate degree from Temple University (Pennsylvania).
Bernhard Mittemeyer active positions
| Companies | Position | Start |
|---|---|---|
| Texas Tech University Health Sciences Center | Corporate Officer/Principal | - |
Former positions of Bernhard Mittemeyer
| Companies | Position | End |
|---|---|---|
Hemobiotech, Inc.
 Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Director/Board Member | - |
Training of Bernhard Mittemeyer
| Temple University (Pennsylvania) | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
- Stock Market
- Insiders
- Bernhard Mittemeyer
